Literature DB >> 3802743

Exploitation of the direct cell damaging action of antifungal azoles.

W H Beggs, C E Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3802743     DOI: 10.1016/0732-8893(87)90108-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


× No keyword cloud information.
  6 in total

1.  Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1992-12       Impact factor: 2.574

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Orally administered antifungal therapy for experimental keratomycosis.

Authors:  D M O'Day
Journal:  Trans Am Ophthalmol Soc       Date:  1990

4.  Requirement for nonprotonated drug molecules in the direct lethal action of miconazole against Candida albicans.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1988-08       Impact factor: 2.574

5.  A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.

Authors:  N V Prajna; R K John; P K Nirmalan; P Lalitha; M Srinivasan
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

6.  Biopharmaceutical Development of a Bifonazole Multiple Emulsion for Enhanced Epidermal Delivery.

Authors:  Joaquim Suñer-Carbó; Ana Calpena-Campmany; Lyda Halbaut-Bellowa; Beatriz Clares-Naveros; María José Rodriguez-Lagunas; Elena Barbolini; Joanna Zamarbide-Losada; Antonio Boix-Montañés
Journal:  Pharmaceutics       Date:  2019-02-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.